ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 6969

$982K Total Retail Price of All Prescriptions

Rank: 141 out of 6969

720 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 720 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,723 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 796 700 1 7
LISINOPRIL 731 622 2 2
SIMVASTATIN 638 571 3 1
LEVOTHYROXINE SODIUM 520 430 4 5
HYDROCODONE-ACETAMINOPHEN 417 322 S3 5 3
BENAZEPRIL HCL 365 311 6 18
LOSARTAN POTASSIUM 337 297 7 12
OMEPRAZOLE 330 283 8 6
PRAVASTATIN SODIUM 322 252 9 19
FENOFIBRATE 314 273 10 63
RANITIDINE HCL 311 273 11 46
GLIMEPIRIDE 280 268 12 44
AMLODIPINE BESYLATE 260 195 13 4
GABAPENTIN 254 217 14 17
JANUVIA 239 198 15 41
SUCRALFATE 235 194 16 247
ALENDRONATE SODIUM 222 206 17 14
ATENOLOL 221 214 18 9
CARVEDILOL 218 207 19 25
TAMSULOSIN HCL 209 187 20 23
NAPROXEN 205 145 21 62
FUROSEMIDE 204 180 22 10
FINASTERIDE 188 175 23 80
TERAZOSIN HCL 186 165 24 49
IBUPROFEN 174 125 25 29
JANUMET 162 129 26 138
KOMBIGLYZE XR 154 121 27 312
METOPROLOL TARTRATE 147 127 28 13
LEVEMIR FLEXPEN 133 104 29 253
ATORVASTATIN CALCIUM 127 115 30 11
ZOLPIDEM TARTRATE 123 107 31 16
DIOVAN 123 103 31 26
METOPROLOL SUCCINATE 118 104 33 22
ONGLYZA 117 113 34 164
LOVASTATIN 116 113 35 15
PLAVIX 114 107 36 68
CLOPIDOGREL 109 108 37 48
CELEBREX 106 90 38 67
BENICAR 101 91 39 107
PANTOPRAZOLE SODIUM 98 98 40 31
FLUOXETINE HCL 95 84 41 43
GLYBURIDE 94 86 R 42 54
CITALOPRAM HBR 93 85 43 34
HYDROCHLOROTHIAZIDE 90 84 44 8
TRAMADOL HCL 84 63 45 27
CRESTOR 83 71 46 39
AVODART 83 77 46 108
WARFARIN SODIUM 79 70 48 20
BACLOFEN 79 42 48 86
PROAIR HFA 75 61 50 33
LYRICA 75 60 50 137
METRONIDAZOLE 74 59 52 316
ESCITALOPRAM OXALATE 74 70 52 93
ALLOPURINOL 73 68 54 35
DICLOFENAC SODIUM 71 64 55 78
NAMENDA 70 70 56 51
VOLTAREN 70 65 56 105
TRIAMCINOLONE ACETONIDE 63 52 58 55
LACTULOSE 62 50 59 131
HYDRALAZINE HCL 62 52 59 106
TRAZODONE HCL 59 44 61 47
FLUTICASONE PROPIONATE 56 34 62 24
GLIPIZIDE 55 48 63 21
DIOVAN HCT 55 42 63 57
PEN NEEDLE 55 47 63 196
MELOXICAM 53 49 66 36
METOCLOPRAMIDE HCL 51 44 67 136
ADVAIR DISKUS 51 42 67 45
FLUCONAZOLE 50 39 69 276
NEXIUM 50 29 69 52
DOXAZOSIN MESYLATE 50 44 69 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.